META SEARCH RESULTS HERE
Pfizer 3-dose COVID vaccine 80% effective against symptomatic omicron infection for youngest children
Am I eligible for a COVID-19 vaccine booster?
Officials expected to offer 2nd booster shot for those over 50 years old
Officials say everyone over 50 can get a 4th COVID shot, but 'especially important' for higher risk people
Amid darkest days of coronavirus pandemic, unprecedented vaccine effort enters final stage
FDA expected to recommend boosters for immunocompromised Americans within weeks: Source
Highly anticipated COVID-19 vaccine data from Pfizer unlikely to come before Election Day: CEO
Pfizer seeks full FDA approval for COVID-19 vaccine beyond current emergency use
Moderna sends vaccine modified for South African variant to NIH for testing
New Pfizer data makes case for booster shots 6 months after primary doses
previous
||
next
Pfizer 3-dose COVID vaccine 80% effective against symptomatic omicron infection for youngest children
By Sony Salzman, Cheyenne Haslett and Eric M. Strauss
May 23, 2022
Story
from Health
Sony Salzman, Cheyenne Haslett, Eric M. Strauss
, ABC News
Am I eligible for a COVID-19 vaccine booster?
By Evan McMurry and Eric M. Strauss
October 12, 2021
Story
from Health
Evan McMurry, Eric M. Strauss
, ABC News
Officials expected to offer 2nd booster shot for those over 50 years old
By Cheyenne Haslett and Eric M. Strauss
March 27, 2022
Story
from Politics
Cheyenne Haslett, Eric M. Strauss
, ABC News
Officials say everyone over 50 can get a 4th COVID shot, but 'especially important' for higher risk people
By Cheyenne Haslett and Eric M. Strauss
March 29, 2022
Story
from Health
Cheyenne Haslett, Eric M. Strauss
, ABC News
Amid darkest days of coronavirus pandemic, unprecedented vaccine effort enters final stage
By Lucien Bruggeman, Josh Margolin, Sony Salzman and Eric M. Strauss
December 14, 2020
Story
from Health
Lucien Bruggeman, Josh Margolin, Sony Salzman, Eric M. Strauss
, ABC News
FDA expected to recommend boosters for immunocompromised Americans within weeks: Source
By Cheyenne Haslett, Eric M. Strauss and Sasha Pezenik
August 5, 2021
Story
from Health
Cheyenne Haslett, Eric M. Strauss, Sasha Pezenik
, ABC News
Highly anticipated COVID-19 vaccine data from Pfizer unlikely to come before Election Day: CEO
By Arielle Mitropoulos and Eric M. Strauss
October 27, 2020
Story
from Health
Arielle Mitropoulos, Eric M. Strauss
, ABC News
Pfizer seeks full FDA approval for COVID-19 vaccine beyond current emergency use
By Eric M. Strauss and William Mansell
May 7, 2021
Story
from Health
Eric M. Strauss, William Mansell
, ABC News
Moderna sends vaccine modified for South African variant to NIH for testing
By Eric M. Strauss, Mark Osborne and Arielle Mitropoulos
February 24, 2021
Story
from Health
Eric M. Strauss, Mark Osborne, Arielle Mitropoulos
, ABC News
New Pfizer data makes case for booster shots 6 months after primary doses
By Sasha Pezenik, Sony Salzman, Eric M. Strauss and Cheyenne Haslett
September 15, 2021
Story
from Politics
Sasha Pezenik, Sony Salzman, Eric M. Strauss, Cheyenne Haslett
, ABC News
previous
||
next
